Polomar Health Services (PMHS) Price to Sales (2022 - 2026)

Polomar Health Services has reported Price to Sales for 5 years, with the latest figure at 2.22 in Q2 2026.

• On a quarterly basis, Price to Sales fell 99.9% year-over-year to 2.22 in Q2 2026; TTM through Jun 2026 was 1.07, a 99.63% decrease from a year earlier, with the FY2025 full-year figure at 34.58, up 5.07% from the prior year.
• Price to Sales was 2.22 for Q2 2026 at Polomar Health Services, down from 4.46 in the prior quarter.
• The five-year high for Price to Sales was 194593.5 in Q4 2022, with the low at 2.22 in Q2 2026.
• Average Price to Sales over 5 years is 16838.5, with a median of 1581.99 recorded in 2023.
• The sharpest annual moves came in 2023 and 2026: Price to Sales soared 710.12% in 2023, then tumbled 99.9% in 2026.
• Over 5 years, Price to Sales stood at 194593.5 in 2022, then sank by 99.48% to 1018.29 in 2023, then plunged by 90.89% to 92.77 in 2024, then tumbled by 61.77% to 35.46 in 2025, then slumped by 93.74% to 2.22 in 2026.
• The last three Price to Sales figures came in at 2.22 (Q2 2026), 4.46 (Q1 2026), and 35.46 (Q4 2025), per Business Quant data.